Risk of Fever After Pediatric Trivalent Inactivated Influenza Vaccine and 13-Valent Pneumococcal Conjugate Vaccine

Authors:

Abstract
During the 2010-2011 influenza season, an epidemiologic study conducted in the Centers for Disease Control and Prevention–supported Vaccine Safety Datalink (VSD) found that trivalent inactivated influenza vaccine (TIV) was associated with an increased risk of febrile seizure during the day of and 1 day after vaccination (days 0-1) in US children who were 6 to 59 months old. Risk was highest among those 6 to 23 months old who received TIV and 13-valent pneumococcal conjugate vaccine (PCV13) simultaneously.1,2 Fever rates were not assessed.

This publication has 18 references indexed in Scilit: